home / stock / cbli / cbli news


CBLI News and Press, Cleveland BioLabs Inc. From 02/18/21

Stock Information

Company Name: Cleveland BioLabs Inc.
Stock Symbol: CBLI
Market: NASDAQ
Website: cbiolabs.com

Menu

CBLI CBLI Quote CBLI Short CBLI News CBLI Articles CBLI Message Board
Get CBLI Alerts

News, Short Squeeze, Breakout and More Instantly...

CBLI - TWLO, RIGL, ONTX and MACK among premarket gainers

Greenland Technologies Holding Corporation (GTEC) +186% on signing co-operation agreement with SOCMA.Immunome (IMNM) +152% on discovery of antibodies neutralizing SARS-CoV-2 variants.Avinger (AVGR) +57%.Heritage Global (HGBL) +42%.U.S. Well Services (USWS) +35%.Cleveland BioLabs (CB...

CBLI - Cleveland Bio files Form S-4 for Cytocom merger, shares up 27%

Cleveland BioLabs (CBLI) soars 27% after-hours after filing Form S-4 with the SEC in connection with its merger agreement with Cytocom, a biopharma creating next-generation immune therapies that deliver immune homeostasis. The Registration Statement is not yet in...

CBLI - Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc.

Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc. Combined public entity to develop and commercialize next-generation immune therapies that address unmet needs in oncology, infectious disease, inflammation and auto-immune-medi...

CBLI - Onconova Therapeutics, Processa Pharmaceuticals leads healthcare gainers; Interpace Biosciences, AIkido Pharma among major losers

Gainers: Onconova Therapeutics (ONTX) +29%, Processa Pharmaceuticals (PCSA) +26%, AnPac Bio-Medical Science ANPC +25%, Oncolytics Biotech ONCY +22%, Cleveland BioLabs (CBLI) +15%.Losers: Interpace Biosciences IDXG -24%, AIkido Pharma AIKI...

CBLI - ICON partners with Cytocom in a Phase 3 trial for Crohn's disease

ICON Public Limited (ICLR) has entered into an agreement with the privately held clinical-stage biotech company, Cytocom to manage the company’s Phase 3 clinical trial for its lead drug candidate, CYTO-201 in Crohn's disease."CYTO-201 is the program's lead clinical asset and we are ple...

CBLI - Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"

Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021" PR Newswire WINTER PARK, Fla. , Dec. 22, 2020 /PRNewswire/ -- Cytocom, Inc. , a leading biopharmaceutical company creating second generation immune t...

CBLI - AJRD, AJIO, NK and LAZR among premarket gainers

EyeGate Pharmaceuticals (EYEG) +87% as it acquires Panoptes Pharma.NantKwest (NK) +32% as its partner, ImmunityBio, achieves primary endpoint in bladder cancer study.RealPage (RP) +31% as Thoma Bravo has agreed to buy the company for $9.6B.China Customer Relations Centers (CCRC...

CBLI - SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - ALXN, ELY, CLCT, CBLI

NEW YORK, NY / ACCESSWIRE / December 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) concerning potential violations of the federal securities laws and/or breaches of f...

CBLI - Penny Stocks To Buy Or Avoid Next Week? 1 Has A 100% Price Target

3 Penny Stocks To Watch Next Week While the end of 2020 can’t come soon enough, there’s still time left to find penny stocks to watch . Throughout 2020, several industries have seen massive growth due to the pandemic. With that, these industries have also promoted siza...

CBLI - WeissLaw LLP Reminds MVC, TNAV, CBLI, and STND Shareholders About Its Ongoing Investigations

WeissLaw LLP Reminds MVC, TNAV, CBLI, and STND Shareholders About Its Ongoing Investigations NEW YORK , Dec. 2, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investiga...

Previous 10 Next 10